Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Crest Whitening Emulsions is a commercially available over-the-counter dental whitening product developed by Procter & Gamble. The formulation consists of a semi-solid cohesive gel characterized by a high concentration of an inert hydrophobic phase (30% to 98% by weight) and a specialized emulsifying system. This system uses a combination of surfactants with varying hydrophilic-lipophilic balances (HLB) to stabilize active whitening agents, typically hydrogen peroxide, within a water-resistant base. This delivery mechanism allows the whitening agent to remain on the tooth surface for extended periods without the need for rinsing, strips, or trays. Beyond its primary use for dental aesthetics, the product has been clinically investigated for its potential to alleviate xerostomia (dry mouth) symptoms. This secondary effect is hypothesized to occur through the stimulation of taste buds by the gel's presence in the oral cavity, which promotes salivary flow, and through the lipid-based lubrication provided by the hydrophobic phase.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Crest Whitening Emulsions.